ArticleCommunications biology2020

Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors.

Paul Savage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.